This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
INN: voriconazole
Data updated: 2026-04-25
Available in:
🇨🇿🇬🇧🇫🇷🇵🇹🇷🇺🇸🇰
Form
—
Dosage
—
Route
—
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Pfizer Europe MA EEIG
ATC Code
J02AC03
Source
EMA · EMEA/H/C/000387
(
ARTG
)
VFEND is indicated for treatment of the following fungal infections: Invasive aspergillosis. Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). Serious fungal infections caused by Scedosporium spp and Fusarium spp. Other serious fungal infections, in patients intolerant of, or refractory to, other therapy. *Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation.
⚠️ Warnings
• Caution should be exercised in patients with history of heart problems, abnormal electrocardiogram (ECG), low level of blood minerals, liver, kidney, pancreas, or blood disease, who have taken chemotherapy treatment, any allergy, who are taking other medications, during pregnancy and breastfeeding.
• It may cause blurred vision or sensitivity to light, do not drive a car or operate machinery while taking this medication.
• Avoid exposure to sunlight.
